Efg Asset Management (North America) Corp. Neurocrine Biosciences Inc Put Options Transaction History
Efg Asset Management (North America) Corp.
- $566 Million
- Q2 2024
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
Others Institutions Holding NBIX
# of Institutions
641Shares Held
95.2MCall Options Held
661KPut Options Held
227K-
Black Rock Inc. New York, NY14.2MShares$1.59 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.13 Billion0.03% of portfolio
-
State Street Corp Boston, MA4.61MShares$516 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.47MShares$276 Million0.6% of portfolio
-
Jpmorgan Chase & CO New York, NY2.36MShares$264 Million0.03% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $10.7B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...